Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women.
Thea ChristoffersenTroels RiisDavid P SonneNiels KlarskovPublished in: International urogynecology journal (2024)
A single dose of 40 mg tadalafil moderately reduced urethral pressure in healthy women, without affecting voiding parameters. The clinical implications of this are yet to be determined.
Keyphrases
- placebo controlled
- double blind
- phase iii
- phase ii
- study protocol
- clinical trial
- polycystic ovary syndrome
- open label
- pregnancy outcomes
- lower urinary tract symptoms
- urinary incontinence
- phase ii study
- cervical cancer screening
- benign prostatic hyperplasia
- randomized controlled trial
- breast cancer risk
- squamous cell carcinoma
- type diabetes
- metabolic syndrome
- radiation therapy